Arnold J - Search Results

1

Efficacy and safety of obinutuzumab in systemic lupus erythematosus patients with secondary non-response to rituximab.

Arnold J, Dass S, Twigg S, Jones CH, Rhodes B, Hewins P, Chakravorty M, Courtney P, Ehrenstein M, Md Yusof MY, Vital EM. Arnold J, et al. Rheumatology (Oxford). 2022 Nov 28;61(12):4905-4909. doi: 10.1093/rheumatology/keac150. Rheumatology (Oxford). 2022. PMID: 35266512

2

COVID-19 vaccination and antirheumatic therapy.

Arnold J, Winthrop K, Emery P. Arnold J, et al. Rheumatology (Oxford). 2021 Aug 2;60(8):3496-3502. doi: 10.1093/rheumatology/keab223. Rheumatology (Oxford). 2021. PMID: 33710296 Free PMC article. Review.

3

A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis.

Arnold J, Vital EM, Dass S, Aslam A, Rawstron AC, Savic S, Emery P, Md Yusof MY. Arnold J, et al. Front Immunol. 2022 Jan 12;12:803175. doi: 10.3389/fimmu.2021.803175. eCollection 2021. Front Immunol. 2022. PMID: 35095887 Free PMC article.

4

Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome.

Pepple S, Arnold J, Vital EM, Rawstron AC, Pease CT, Dass S, Emery P, Md Yusof MY. Pepple S, et al. Among authors: arnold j. ACR Open Rheumatol. 2022 Aug;4(8):689-699. doi: 10.1002/acr2.11466. Epub 2022 Jun 5. ACR Open Rheumatol. 2022. PMID: 35666029 Free PMC article.

5

Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study.

Md Yusof MY, Arnold J, Saleem B, Vandevelde C, Dass S, Savic S, Vital EM, Emery P. Md Yusof MY, et al. Among authors: arnold j. Lancet Rheumatol. 2023 Feb;5(2):e88-e98. doi: 10.1016/S2665-9913(23)00004-8. Epub 2023 Jan 10. Lancet Rheumatol. 2023. PMID: 36712951 Free PMC article.

6

Defining myocardial fibrosis in haemodialysis patients with non-contrast cardiac magnetic resonance.

Graham-Brown MP, Singh AS, Gulsin GS, Levelt E, Arnold JA, Stensel DJ, Burton JO, McCann GP. Graham-Brown MP, et al. Among authors: arnold ja. BMC Cardiovasc Disord. 2018 Jul 13;18(1):145. doi: 10.1186/s12872-018-0885-2. BMC Cardiovasc Disord. 2018. PMID: 30005636 Free PMC article.

7

Thy-1 restricts steatosis and liver fibrosis in steatotic liver disease.

Blank V, Karlas T, Anderegg U, Wiegand J, Arnold J, Bundalian L, Le Duc GD, Körner C, Ebert T, Saalbach A. Blank V, et al. Among authors: arnold j. Liver Int. 2024 May 4. doi: 10.1111/liv.15956. Online ahead of print. Liver Int. 2024. PMID: 38702958

8

Cannabinoids and healthy ageing: the potential for extending healthspan and lifespan in preclinical models with an emphasis on Caenorhabditis elegans.

Wang Z, Arnold JC. Wang Z, et al. Among authors: arnold jc. Geroscience. 2024 May 2. doi: 10.1007/s11357-024-01162-8. Online ahead of print. Geroscience. 2024. PMID: 38696056 Review.

9

Cognitive Impairment in the Primary Care Clinic.

Womack CL, Perkins A, Arnold JM. Womack CL, et al. Among authors: arnold jm. Prim Care. 2024 Jun;51(2):233-251. doi: 10.1016/j.pop.2024.02.010. Epub 2024 Apr 1. Prim Care. 2024. PMID: 38692772 Review.

10

Toward Circular Recycling of Polyurethanes: Depolymerization and Recovery of Isocyanates.

O'Dea RM, Nandi M, Kroll G, Arnold JR, Korley LTJ, Epps TH 3rd. O'Dea RM, et al. Among authors: arnold jr. JACS Au. 2024 Apr 11;4(4):1471-1479. doi: 10.1021/jacsau.4c00013. eCollection 2024 Apr 22. JACS Au. 2024. PMID: 38665666 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,796 results

Search Page